Connected Insulin Pens and Caps : An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
Tejera Pérez, Cristina (Complejo Hospitalario Universitario de Ferrol)
Chico, Ana (Institut d'Investigació Biomèdica Sant Pau)
Azriel, Sharona (Hospital Universitario Infanta Sofia (Madrid))
Lardiés-Sánchez, Beatriz (Hospital Obispo Polanco (Terol, Aragó))
Gómez-Peralta, Fernando (Hospital General de Segovia)
Amor Fernández Antonio, Jesús
Bartual Rodrigo, Amparo
Bellido, Virginia
Bellido Guerrero, Diego
Botana Lopez Manuel, Antonio
Brito Sanfiel, Miguel
Canovas Molina, Gloria
Cepero Garcia, Daniel
Conget, Ignacio
de Luis Román Daniel, Antonio
Durán Martínez, María
Duran Rodriguez Hervada, Alejandra
Escalada San Martin Francisco, Javier
Fernández García, Carlos
Fernández García, Diego
García Fernández, Elena
García Jiménez, Custodia
Gargallo Fernández, Manuel
Gómez Peralta, Fernando
González Blanco, Cintia (Institut d'Investigació Biomèdica Sant Pau)
González Clemente, José Miguel
De Villar Noemí, González Pérez
Gros Herguido, Noelia
Hernandez Martinez Antonio, Miguel
Herranz Antolin, Sandra
Jodar, Esteban
Lecumberri Pascual, Edurne
De La Torre Casares Martin, L.
López Fernández, Judith
López Gallardo, Gema
Marco Martinez, Amparo
Merino Torres Juan, Francisco
Mezquita Raya, Pedro
Morales Portillo, Cristóbal
Moreno Pérez, Óscar
Muñoz Torres, Manuel
De Pablos-Velasco, Pedro Luis
Pinés Corrales Pedro, José
Quílez Toboso Rosa, Pilar
Reyes García, Rebeca
Rozas Moreno, Pedro
Rodríguez Carnero María, Gemma
Universitat Autònoma de Barcelona

Date:	2023
Abstract:	Undoubtedly, technological advances have revolutionised diabetes management in recent years. The development of advanced closed hybrid loop insulin pumps or continuous glucose monitoring (CGM) systems, among others, have increased the quality of life and improved glycaemic control of people with diabetes. However, only some patients have access to such technology, and only some want to use it. CGM has become much more widespread, but in terms of insulin delivery, most people with type 1 diabetes (T1D) and almost all people with type 2 diabetes (T2D) on insulin therapy are treated with multiple-dose insulin injections (MDI) rather than an insulin pump. For these patients, using connected insulin pens or caps has shown benefits in reducing missed insulin injections and promoting correct administration over time. In addition, using these devices improves the quality of life and user satisfaction. The integration of insulin injection and CGM data facilitates both users and the healthcare team to analyse glucose control and implement appropriate therapeutic changes, reducing therapeutic inertia. This expert's recommendation reviews the characteristics of the devices marketed or in the process of being marketed and their available scientific evidence. Finally, it suggests the profile of users and professionals who would benefit most, the barriers to its generalisation and the changes in the care model that implementing these devices can bring with it.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Connected insulin caps ; Connected insulin pens ; Diabetes ; Digital health ; Multiple daily insulin therapy
Published in:	Diabetes Therapy, Vol. 14 Núm. 7 (july 2023) , p. 1077-1091, ISSN 1869-6961

DOI: 10.1007/s13300-023-01417-1
PMID: 37188930

15 p, 463.4 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles